Cite
HARVARD Citation
Reinisch, M. et al. (2022). Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study. Breast. pp. 110-117. [Online].